Suberoylanilide hydroxamic acid – a potential epigenetic therapeutic agent for lung fibrosis?

Suberoylanilide hydroxamic acid – a potential epigenetic therapeutic agent for lung fibrosis?

Pulmonary fibrosis represents a fatal stage of interstitial lung diseases of known and idiopathic aetiology. No effective therapy is currently available. Based on an indication-discovery approach we present novel in vitro evidence that the histone deacetylases inhibitor suberoylanilide hydroxamic ac...

Full description

Bibliographic Details
Main Authors: Wang, Z., Chen, C., Finger, S., Kwajah, M., Jung, M., Schwarz, H., Swanson, N., Lareu, Ricardo, Raghunath, M.
Format: Journal Article
Published: European Respiratory Society 2009
Subjects:
suberoylanilide hydroxamic acid
pulmonary fibrosis
collagen
Antifibrotic
histone deacetylase inhibitor
fibroblast
Online Access:http://hdl.handle.net/20.500.11937/34604

Internet

http://hdl.handle.net/20.500.11937/34604

Similar Items